Oncolink Features

Find My Cancer Drug

Tipos de Cancer / Cánceres del Hueso / Sarcoma de Ewing / Exámenes de Detección

Link to OncoLink

NCI CANCERLIT^® Search: Tuberous Sclerosis - March 2002

Imprima English

National Cancer Institute^®
Ultima Vez Modificado: 1 de marzo del 2002

Mutation analysis of the TSC1 and 7TC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.

Acrofacial dysostosis in a patient with the TSC2-PKD1 contiguous gene syndrome.

Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.

Analysis of the TSC2 gene in human medulloblastoma.

Tuberous sclerosis complex genes: from flies to human genetics.

Treatment of the pulmonary involvement in the patient with tuberous sclerosis complex.

[Molecular mechanisms of oncogenic transformation: what's new?]

Table of Contents

1
UI - 11829138
AU - Sato T; Seyama K; Fujii H; Maruyama H; Setoguchi Y; Iwakami S; Fukuchi
TI - Y; Hino O Mutation analysis of the TSC1 and 7TC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.
SO - J Hum Genet 2002;47(1):20-8
AD - Department of Respiratory Medicine Juntendo University, School of Medicine, Tokyo, Japan.
Pulmonary lymphangioleiomyomatosis (LAM) is a destructive lung disease characterized by a diffuse hamartomatous proliferation of smooth muscle cells (LAM cells) in the lungs. Pulmonary LAM can occur as an isolated form (sporadic LAM) or in association with tuberous sclerosis complex (TSC) (TSC-LAM), a genetic disorder with autosomal dominant inheritance with various expressivity resulting from mutations of either the TSC1 or TSC2 gene. We examined mutations of both TSC genes in 6 Japanese patients with TSC-LAM and 22 patients with sporadic LAM and identified six unique and novel mutations. TSC2 germline mutations were detected in 2 (33.3%) of 6 patients with TSC-LAM and TSC1 germline mutation in 1 (4.5%) of 22 sporadic LAM patients. In accordance with the tumor-suppressor model, loss of heterozygosity (LOH) was detected in LAM cells from 3 of 4 patients with TSC-LAM and from 4 of 8 patients with sporadic LAM. Furthermore, an identical LOH or two identical somatic mutations were demonstrated in LAM cells microdissected from several tissues, suggesting LAM cells can spread from one lesion to another. Our results from Japanese patients with LAM confirmed the current concept of pathogenesis of LAM: TSC-LAM has a germline mutation but sporadic LAM does not; sporadic LAM is a TSC2 disease with two somatic mutations; and a variety of TSC mutations causes LAM. However, our study indicates that a fraction of sporadic LAM can be a TSC1 disease; therefore, both TSC genes should be examined, even for patients with sporadic LAM.

2
UI - 11836366
AU - Dauwerse JG; Bouman K; van Essen AJ; van Der Hout AH; Kolsters G;
TI - Breuning MH; Peters DJ Acrofacial dysostosis in a patient with the TSC2-PKD1 contiguous gene syndrome.
SO - J Med Genet 2002 Feb;39(2):136-41

3
UI - 11853018
AU - Miloloza A; Kubista M; Rosner M; Hengstschlager M
TI - Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.
SO - J Neuropathol Exp Neurol 2002 Feb;61(2):154-63
AD - Department of Obstetrics and Gynecology, University of Vienna, Prenatal Diagnosis and Therapy, Wahringer Gurtel, Austria.
Tuberous sclerosis is an autosomal dominant disease affecting approximately 1 in 6,000 individuals. It is caused by mutations in either TSC1 on chromosome 9q34, which encodes hamartin, or TSC2 on chromosome 16p13.3, which encodes tuberin. The growths, named hamartomas, characteristically occur in different organs of patients and are speculated to result from defects in proliferation control. The observation that hamartin and tuberin can interact in vivo suggests that they might function in the same complex. Here we show that hamartin can affect proliferation control independent of the presence of functional tuberin and that binding to hamartin is not essential for tuberin to affect proliferation. Ectopic expression of hamartin negatively regulates proliferation to a similar extent in tuberin-positive and tuberin-negative cells; this is accompanied by binding to tuberin and upregulation of endogenous p27 in tuberin-positive cells and is without effects on p27 expression in the latter. Our data show for the first time that TSC proteins possess separable functions. We further demonstrate that hamartin can deregulate proliferation control by different mechanisms depending on the presence of tuberin. Besides an overlap in many features of patients with TSC1 and TSC2 mutations, data has accumulated that provides evidence for specific clinical differences. This study provides new insights into the cellular roles of TSC proteins and initiates a discussion of whether separable functions of these proteins might be associated with the clinical differences of TSC1- and TSC2-associated disease.

4
UI - 11603814
AU - Przkora R; Meyer-Puttlitz B; Schmitt O; Berthold F; Nothen M; Krauss J;
TI - Tonn JC; von Deimling A; Wiestler OD; Pietsch T Analysis of the TSC2 gene in human medulloblastoma.
SO - Acta Neuropathol (Berl) 2001 Oct;102(4):380-4
AD - Department of Neuropathology, University of Bonn Medical Center, Germany.
Medulloblastoma (MB) represents the most frequent malignant brain tumor of childhood. Recent studies have shown that deregulation of developmental control genes may play an important role in its pathogenesis. Tuberous sclerosis is associated with hamartomas and cortical tubers, consisting of both glial and neuronal cellular components. MBs can also show markers of these lineages, raising the question of the potential involvement of TSC genes in these malignant tumors. Here we investigated tuberous sclerosis 2 (TSC2), one of the two genes responsible for tuberous sclerosis, in sporadic MBs. We analyzed MBs for allelic losses at the TSC2 locus and for the frequency of a polymorphism first described in gangliogliomas. Sixty-eight MBs were examined for this polymorphism located in intron 4, 3 base pairs 5' to the first coding nucleotide of exon 5. The distribution of the alleles was significantly different in MBs as compared to 208 control samples, (P=0.0017, Chi-square test). In MBs the frequency of the rare allele (A2) was 0.184 (18.4%), whereas in the control group it occurred in a frequency of 8.7%. Microsatellite analysis of the TSC2 region in 50 tumors did not identify allelic losses. TSC2 mRNA transcript was detectable via reverse transcription-PCR in all tumors as well as in normal cerebellum. Northern blot analysis of an MB cell line homozygous for the rare allele of the polymorphism and two other cell lines homozygous for the frequent allele revealed normal splicing patterns and normal expression levels of the TSC2 transcript. These findings may indicate that the presence of the rare TSC2 allele is associated with a predisposition for the development of MBs.

5
UI - 11686512
AU - Hengstschlager M
TI - Tuberous sclerosis complex genes: from flies to human genetics.
SO - Arch Dermatol Res 2001 Aug;293(8):383-6
AD - Obstetrics and Gynecology, University of Vienna, Prenatal Diagnosis and Therapy, Wahringer Gurtel, Austria. markus.hengstschlaeger@akh-wien.ac.at

6
UI - 11688396
AU - Roccatello D; Obert R; Sena GM; Longa L; Rossi D; Grosso E; Cavallo R;
TI - Sena LM; Giachino O; Migone N Treatment of the pulmonary involvement in the patient with tuberous sclerosis complex.
SO - Contrib Nephrol 2001;(136):292-8
AD - Centro Multidisciplinare di Immunopatologia e Documentazione su Malattie Rare (CMID), Presidi Ospedalieri ASL4, sede Osp. Luigi Einaudi, Torino, Italia. cmid@iol.it

7
UI - 11847020
AU - Blanchard JM
TI - [Molecular mechanisms of oncogenic transformation: what's new?]
SO - Bull Cancer 2002 Jan;89(1):9-16
AD - Institut de genetique moleculaire, CNRS, UMR5535, IFR24, 1919, route de Mende, 34293 Montpellier Cedex 5.
During the past two years, new molecular targets have been discovered which link cell cycle, cell proliferation and cellular growth. It has become more and more evident that whereas gain-of-function mutations in specific genes can lead to cancer, genomic instability plays also an important role in tumour progression. With examples taken from the recent literature, we describe in this short review crucial findings on the molecular mechanisms controlling cell cycle and proliferation. We illustrate how specific combinations of proto-oncogenes alterations can result in tissue-specific tumours. Finally, impairment of the interactions of a cancer cell with its surrounding neighbours is also shown to participate in the progression toward aggressive phenotypes.

The above citations and abstracts reflect those newly added to CANCERLIT for the month and topic listed in the title. The citations have been retrieved from CANCERLIT using a predefined search strategy of indexed subject terms. Although the search strategy has been refined as best as possible, citations may appear that are not directly related to the topic, and occasionally relevant references may be omitted.

OncoLink I wish u knew...

Dr. Glatstein shares some of the important lessons he has conveyed upon the many oncology professionals he has trained. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews

Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement